Next Frontiers for CD30-Positive Lymphoma Treatment
Next Frontiers for CD30-Positive Lymphoma Treatment is organized by Projects In Knowledge Inc. (PIK)..
Release Date: Jan 22, 2023
Termination Date: Jan 21, 2024
Activity Goal:
The goal of this program is to provide data from medical meetings, expert analysis insights on current and emerging management strategies, and interactive case studies based on the most up-to-date evidence-based medicine and clinical trial results in cHL.
Learning Objective(s):
• Summarize emerging safety and efficacy data for newer and investigational treatment regimens for cHL.
• Devise individualized management plans for children, adolescent, and adult patients with cHL consistent with the latest evidence.
Additional details will be posted as soon as information is available.